Summary & Overview
HCPCS G9757: Surgical Use of Silicone Oil
Headline: HCPCS Level II G9757: Silicone Oil Use in Vitreoretinal Surgery
Lead: HCPCS Level II code G9757 identifies surgical procedures in which silicone oil was used as an intraocular tamponade during vitreoretinal operations. The code is relevant across hospital outpatient departments and ambulatory surgery centers and matters for national billing consistency and clinical documentation around complex retinal surgeries.
What the code represents and why it matters: G9757 is used to flag cases where silicone oil was employed to manage retinal detachments or other severe vitreoretinal conditions. Proper coding supports accurate clinical records, claims processing, and downstream payment and quality measurement for high-complexity ophthalmic surgeries.
Key payers covered: This analysis addresses major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare to reflect common coverage and billing considerations at scale.
What readers will learn: The publication presents concise benchmarks and policy context for G9757, clarifies typical sites of service and clinical scenarios for silicone oil use, and outlines common modifier and claim considerations where data is available. It also highlights areas labeled "Data not available in the input" when specific payer policies, related taxonomies, or ICD-10 pairings are not provided.
Billing Code Overview
HCPCS Level II code G9757 describes surgical procedures that included the use of silicone oil. The service type is intraocular surgical procedure involving tamponade with silicone oil, typically performed during vitreoretinal surgery.
Typical site of service is hospital outpatient department or ambulatory surgery center, and procedures are delivered by ophthalmic surgeons specializing in vitreoretinal care.
Clinical & Coding Specifications
Clinical Context
A 62-year-old phakic male with a history of proliferative diabetic retinopathy, tractional retinal detachment, and recurrent vitreous hemorrhage presents with decreased vision and persistent retinal traction despite prior vitrectomy. The vitreoretinal surgeon elects to perform pars plana vitrectomy with membrane peel, endolaser, fluid–air exchange and placement of long‑term silicone oil tamponade to reattach the retina and stabilize the posterior segment.
Preoperative workflow includes ocular history, visual acuity, intraocular pressure measurement, slit lamp exam, dilated fundus exam, and optical coherence tomography when obtainable. Informed consent addresses risks of silicone oil such as cataract progression, elevated intraocular pressure, and need for future oil removal. On the day of service the patient undergoes anesthesia evaluation (general or monitored anesthesia care), sterile preparation, standard three‑port pars plana vitrectomy, membrane dissection, laser photocoagulation, and silicone oil instillation with wound closure. Postoperative care includes topical antibiotics, corticosteroids, intraocular pressure monitoring, and planned follow‑up for oil removal or long‑term management as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the service required substantially greater work than typical (document rationale and additional work). |